“Gene Therapy for Neuromuscular Diseases and Immune Response” network

Coordinated by Prof. Olivier Beneveniste from the Institut de Myologie and Dr Carole Masurier from Genethon, this network hopes to come up with clinical strategies that can be used to control immune responses during gene therapy for muscular disorders, since such responses can affect treatment efficacy.